SGHT Q1 2023 Earnings — Sight Sciences, Inc. Revenue & Financial Results | Market Cap Arena

SGHTSight Sciences, Inc.

$224M

Q1 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$19M+26.5% YoY

Gross Profit

$16M83.8% margin

Operating Income

-$18M-93.3% margin

Net Income

-$17M-90.7% margin

EPS (Diluted)

$-0.35

QoQ Revenue Growth

-8.4%

Cash Flow

Operating Cash Flow

-$17M

Free Cash Flow

-$18M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$197M

Total Liabilities

$50M

Stockholders' Equity

$146M

Cash & Equivalents

$167M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$19M	$15M	+26.5%
Gross Profit	$16M	$12M	+33.2%
Operating Income	-$18M	-$22M	+20.8%
Net Income	-$17M	-$23M	+26.6%

Revenue Segments

Surgical Glaucoma

$17M92%

Dry Eye

$1M8%